JP2008528446A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528446A5
JP2008528446A5 JP2007549559A JP2007549559A JP2008528446A5 JP 2008528446 A5 JP2008528446 A5 JP 2008528446A5 JP 2007549559 A JP2007549559 A JP 2007549559A JP 2007549559 A JP2007549559 A JP 2007549559A JP 2008528446 A5 JP2008528446 A5 JP 2008528446A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
component
nanoparticles
composition according
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007549559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528446A (ja
JP5384831B2 (ja
Filing date
Publication date
Priority claimed from US11/029,082 external-priority patent/US7265090B2/en
Priority claimed from US11/284,734 external-priority patent/US7282194B2/en
Application filed filed Critical
Publication of JP2008528446A publication Critical patent/JP2008528446A/ja
Publication of JP2008528446A5 publication Critical patent/JP2008528446A5/ja
Application granted granted Critical
Publication of JP5384831B2 publication Critical patent/JP5384831B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007549559A 2005-01-04 2005-12-27 タンパク質ドラッグデリバリ用ナノ粒子 Expired - Fee Related JP5384831B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/029,082 US7265090B2 (en) 2004-10-05 2005-01-04 Nanoparticles for paracellular drug delivery
US11/029,082 2005-01-04
US11/284,734 2005-11-21
US11/284,734 US7282194B2 (en) 2004-10-05 2005-11-21 Nanoparticles for protein drug delivery
PCT/US2005/047125 WO2006073950A2 (en) 2005-01-04 2005-12-27 Nanoparticles for protein drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013112996A Division JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Publications (3)

Publication Number Publication Date
JP2008528446A JP2008528446A (ja) 2008-07-31
JP2008528446A5 true JP2008528446A5 (cg-RX-API-DMAC7.html) 2009-02-12
JP5384831B2 JP5384831B2 (ja) 2014-01-08

Family

ID=36648027

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007549559A Expired - Fee Related JP5384831B2 (ja) 2005-01-04 2005-12-27 タンパク質ドラッグデリバリ用ナノ粒子
JP2013112996A Pending JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013112996A Pending JP2013177434A (ja) 2005-01-04 2013-05-29 タンパク質ドラッグデリバリ用ナノ粒子

Country Status (8)

Country Link
US (4) US7282194B2 (cg-RX-API-DMAC7.html)
EP (1) EP1833470A4 (cg-RX-API-DMAC7.html)
JP (2) JP5384831B2 (cg-RX-API-DMAC7.html)
CN (1) CN101360486B (cg-RX-API-DMAC7.html)
AU (1) AU2005322940B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518093A (cg-RX-API-DMAC7.html)
CA (1) CA2592991C (cg-RX-API-DMAC7.html)
WO (1) WO2006073950A2 (cg-RX-API-DMAC7.html)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137697B1 (en) * 2004-10-05 2012-03-20 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
US7901711B1 (en) * 2006-04-17 2011-03-08 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7879361B2 (en) * 2005-01-04 2011-02-01 Gp Medical, Inc. Nanoparticles for drug delivery
US7541028B2 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for monoclonal antibody delivery
EP1774971A1 (en) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Chitosan and heparin nanoparticles
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2007100588A1 (en) * 2006-02-27 2007-09-07 Edwards Lifesciences Corporation Hydrogel for an intravenous amperometric biosensor
JP2007291324A (ja) * 2006-03-31 2007-11-08 Jsr Corp 酸化物微粒子含有ポリシロキサン組成物およびその製造方法
JP2007270056A (ja) * 2006-03-31 2007-10-18 Jsr Corp 金属酸化物微粒子含有ポリシロキサン組成物およびその製造方法
US8449915B1 (en) * 2006-04-17 2013-05-28 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
JP2009541485A (ja) * 2006-06-26 2009-11-26 ミューチュアル ファーマシューティカル カンパニー，インク． 活性剤組成物
US20080160096A1 (en) * 2006-07-27 2008-07-03 Janos Berbely Polymeric nanoparticles by ion-ion interactions
CN101148511B (zh) * 2006-09-18 2010-10-20 中国科学院过程工程研究所 荧光壳聚糖微球的制备方法及其在示踪剂领域的应用
US8946200B2 (en) * 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
US8460726B2 (en) * 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
US20080193547A1 (en) * 2006-12-27 2008-08-14 Janos Borbely Polymeric nanoparticles by ion-ion Interactions
WO2008141107A2 (en) * 2007-05-09 2008-11-20 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
WO2009035438A1 (en) * 2007-09-13 2009-03-19 Janos Borbely Polymeric nanoparticles by ion-ion interactions
WO2009065181A1 (en) * 2007-11-21 2009-05-28 Apollo Life Sciences Limited Nanostructures suitable for delivery of agents
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
US8404850B2 (en) * 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
CN102216381B (zh) * 2008-04-24 2016-06-15 麦德托尼克公司 可再水化的多糖颗粒和海绵体
AU2009240512B2 (en) * 2008-04-24 2014-07-10 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
WO2009132224A2 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
AU2009240513B2 (en) * 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
AU2009240511B2 (en) * 2008-04-24 2015-01-22 Medtronic, Inc. Thiolated chitosan gel
US20110189299A1 (en) * 2008-07-01 2011-08-04 Nitto Denko Corporation Pharmaceutical composition containing surface-coated microparticles
US8722706B2 (en) * 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
US20100104608A1 (en) * 2008-09-26 2010-04-29 Tyco Healthcare Group Lp Reactive surgical implant
US8309134B2 (en) * 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
US20100111919A1 (en) * 2008-10-31 2010-05-06 Tyco Healthcare Group Lp Delayed gelation compositions and methods of use
JP2010132609A (ja) * 2008-12-05 2010-06-17 Fujifilm Corp カゼインナノ粒子
US20100159010A1 (en) * 2008-12-24 2010-06-24 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
WO2010087781A1 (en) * 2009-01-28 2010-08-05 Agency For Science, Technology And Research Polyelectrolyte complexes with bound peptides
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
EP2435554B1 (en) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US8404281B2 (en) * 2009-06-08 2013-03-26 Avant Garde Therapeutics & Technologies Llc Formulations
KR101342641B1 (ko) 2009-06-25 2013-12-20 주식회사 바이오리더스 폴리감마글루탐산-키토산 나노입자를 함유하는 면역보강제 조성물
AU2010269815B2 (en) 2009-07-09 2015-10-15 Oshadi Drug Administration Ltd. Matrix carrier compositions, methods and uses
US8637096B2 (en) 2009-12-04 2014-01-28 Curtis C. Stojan Compositions and method for enhancing insulin activity
CA2785815C (en) 2010-01-28 2018-04-24 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US9028873B2 (en) * 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
WO2011100460A2 (en) * 2010-02-11 2011-08-18 Ecole Polytechnique Federale De Lausanne Ccr7 ligand delivery and co-delivery in immunotherapy
JP2011178764A (ja) * 2010-03-04 2011-09-15 Ajinomoto Co Inc 腸内ビフィズス菌増殖促進剤および腸管バリア機能改善剤
EP2417968A1 (en) 2010-07-29 2012-02-15 Consorzio per il Centro di Biomedicina Molecolare Scrl Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
NZ607226A (en) 2010-08-13 2015-03-27 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
WO2012075414A2 (en) 2010-12-02 2012-06-07 Ecosynthetix Ltd. Aptamer bioconjugate drug delivery device
US9713702B2 (en) * 2011-03-14 2017-07-25 The Board Of Trustee Of The Leland Stanford Junior University Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
WO2012170017A1 (en) * 2011-06-08 2012-12-13 Avant Garde Therapeutics Inc. Novel formulations
JP6346561B2 (ja) 2011-06-13 2018-06-20 ライバル，ソシエテ エン コマンダイト Ｎ，ｎ，ｎ−トリアルキルポリマー、その調製方法およびその使用
JP5801626B2 (ja) * 2011-06-30 2015-10-28 国立大学法人信州大学 複合ナノ繊維の製造方法
AU2012318273B2 (en) * 2011-12-02 2016-05-19 Greenmark Biomedical Inc. Aptamer bioconjugate drug delivery device
US8883717B2 (en) * 2012-03-30 2014-11-11 Artificial Cell Technologies, Inc. Antigenic compositions and methods
US10555911B2 (en) 2012-05-04 2020-02-11 Yale University Highly penetrative nanocarriers for treatment of CNS disease
US8313774B1 (en) 2012-06-26 2012-11-20 Magnifica Inc. Oral solid composition
TWI511744B (zh) * 2013-01-09 2015-12-11 Univ Nat Cheng Kung 可任意調整介面電荷與粒徑大小之生物可分解載體、其製備方法及含彼之醫藥組合物
US11504422B2 (en) 2013-01-09 2022-11-22 National Cheng Kung University Biodegradable nanocomplex
WO2015032971A1 (en) * 2013-09-09 2015-03-12 Lek Pharmaceuticals D.D. Polymer selection for preparation of nps with high protein loading
EP3052091B1 (en) 2013-10-01 2019-04-24 Lifecare Innovations Pvt. Ltd. Sustained release formulations containing methylglyoxal and their therapeutic applications
CN113813401A (zh) * 2013-11-05 2021-12-21 埃琳娜·莫洛卡诺瓦 用于调节受体和离子通道的位置特异性亚型的纳米结构轭合物
CN103656623B (zh) * 2013-12-06 2015-04-15 南通大学 载有神经营养因子的纳米微球及制备和用途
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
JP2017521479A (ja) 2014-05-15 2017-08-03 ラニ セラピューティクス， エルエルシー ポリペプチドおよび／またはタンパク質を含む固体塊の薬学的組成物およびそれを製造するための方法
US20170304374A1 (en) * 2014-10-23 2017-10-26 Symbiotic Health Inc. Capsule for the oral administration of biopharmaceuticals
AU2016257813B2 (en) * 2015-05-01 2021-05-13 Rani Therapeutics, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
CN108347982A (zh) 2015-07-29 2018-07-31 高级生物营养公司 用于特殊饮食用途的稳定的干燥益生菌组合物
KR101882820B1 (ko) 2015-12-30 2018-07-30 주식회사 삼양바이오팜 점막부착성 약학 조성물 및 그의 제조방법
US11491114B2 (en) 2016-10-12 2022-11-08 Curioralrx, Llc Formulations for enteric delivery of therapeutic agents
WO2018136061A1 (en) * 2017-01-19 2018-07-26 Sun Yat-Sen University Therapeutic protein-loaded nanoparticle and method for preparing the same
CN107651664B (zh) * 2017-10-16 2020-11-06 浙江领蔚生物技术有限公司 一种荧光碳纳米粒子及用作细胞标记材料的用途
CA3090303A1 (en) 2018-03-28 2019-10-03 Greenmark Biomedical Inc. Phosphate crosslinked starch nanoparticle and dental treatments
US20240315972A1 (en) 2021-07-12 2024-09-26 Zidkiyahu Simenhaus Protein containing bio-active compositions comprising cellulose microparticle carriers
CN114470186B (zh) * 2022-02-17 2023-10-20 唐颐控股(深圳)有限公司 一种可吸入式纳米新冠疫苗的制备方法
KR20250144708A (ko) * 2024-03-27 2025-10-13 한국과학기술연구원 올리고감마글루탐산 유도체 기반의 신규한 지질 및 이를 포함하는 지질나노입자와 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69411154T2 (de) * 1993-02-22 1998-10-22 Alza Corp., Palo Alto, Calif. Mittel zur oralen gabe von wirkstoffen
US5510118A (en) * 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
IE80468B1 (en) * 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
AU720989B2 (en) * 1996-07-10 2000-06-22 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Gene therapy delivery system for targeting to endothelia
US6933331B2 (en) * 1998-05-22 2005-08-23 Nanoproducts Corporation Nanotechnology for drug delivery, contrast agents and biomedical implants
US5972389A (en) * 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
IE970794A1 (en) * 1997-09-24 2000-08-23 Elan Corp Plc Composition and method for enhancing paracellular transport across cell layers
US6726934B1 (en) * 1997-10-09 2004-04-27 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
WO1999018934A1 (en) * 1997-10-09 1999-04-22 Vanderbilt University Micro-particulate and nano-particulate polymeric delivery system
US6517869B1 (en) * 1997-12-12 2003-02-11 Expression Genetics, Inc. Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
FR2780901B1 (fr) * 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
AU4476600A (en) * 1999-04-22 2000-11-10 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
CA2372461A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
EP1194128A2 (en) * 1999-06-23 2002-04-10 Sedum Laboratories Ionically formulated biomolecule microcarriers
WO2001019405A2 (de) * 1999-09-14 2001-03-22 Biomedical Apherese Systeme Gmbh Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung
GB0126923D0 (en) * 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
US7482018B2 (en) * 2001-12-21 2009-01-27 Soane Family Trust Use of oligomers and polymers for drug solubilization, stabilization, and delivery
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7265090B2 (en) * 2004-10-05 2007-09-04 Gp Medical, Inc. Nanoparticles for paracellular drug delivery
US7879819B1 (en) * 2005-01-04 2011-02-01 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7611690B2 (en) * 2005-01-04 2009-11-03 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7541046B1 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7604795B1 (en) * 2005-01-04 2009-10-20 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7541028B2 (en) * 2005-01-04 2009-06-02 Gp Medical, Inc. Nanoparticles for monoclonal antibody delivery
US7291598B2 (en) * 2005-01-04 2007-11-06 Gp Medical, Inc. Nanoparticles for protein drug delivery
US20070148251A1 (en) * 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices

Similar Documents

Publication Publication Date Title
JP2008528446A5 (cg-RX-API-DMAC7.html)
WO2006073950B1 (en) Nanoparticles for protein drug delivery
Subramanian et al. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
Wong Chitosan and its use in design of insulin delivery system
CN1993113B (zh) 包含磷酸钙纳米颗粒核心，生物分子和胆汁酸的颗粒，其生产方法，其治疗用途
Paul et al. Chitosan, a drug carrier for the 21* century: a review
CN101137700B (zh) 微粒及医药组合物
Ariful Islam et al. Mucoadhesive chitosan derivatives as novel drug carriers
US11471422B2 (en) Stealth, targeted nanoparticles (STN) for oral drug delivery
US9101547B2 (en) Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery
JP6533232B2 (ja) 親水性活性化合物のナノカプセル化
CN102970864A (zh) 纳米颗粒药物组合物
CN111672018B (zh) 载药医疗器械及制备方法、药物球囊、药物涂层制备方法
Michalak et al. Polymeric nanoparticles–a novel solution for delivery of antimicrobial agents
Ong et al. Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review
Chen et al. Current therapeutic strategy in the nasal delivery of insulin: recent advances and future directions
CN105381472B (zh) 月见草素b-酪蛋白磷酸肽-壳聚糖纳米粒及制备方法与应用
US20060134785A1 (en) Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same
Erten Taysi et al. The efficacy of sustained-release chitosan microspheres containing recombinant human parathyroid hormone on MRONJ
Parhi Chitin and chitosan in drug delivery
Sharaf et al. Chitin and chitosan applications in medication delivery systems
ES2969208T3 (es) Composiciones de ácido gamma-poliglutámico y zinc
EP3975927B1 (en) Mucoadhesive microgel compositions and methods for using the same
Das et al. Chitosan-based systems for oral drug delivery applications
Kriplani et al. Chitosan-A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review